A specialty vaccine company is seeking grant funding to ramp up production of a potential inoculation against Covid-19 from its Scottish laboratory. French-headquartered Valneva is in discussions with the Coalition for Epidemic Preparedness Innovations (CEPI) after partnering with US-listed Dynavax to develop a vaccine candidate in response to the coronavirus pandemic. The project is currently at the pre-clinical stage, but is expected to reach clinical trials before the end of the year.